151 related articles for article (PubMed ID: 859645)
21. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.
DeLuca HF
N Engl J Med; 1973 Aug; 289(7):359-65. PubMed ID: 4578017
[No Abstract] [Full Text] [Related]
22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of hypoparathyroidism. Trials of 1 alpha-hydroxycholecalciferol (1 alpha-(OH)D3)].
Jorgensen H; Vogt JH
Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1069-72. PubMed ID: 905981
[No Abstract] [Full Text] [Related]
24. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
von Herrath D; Kraft D; Grigoleit HG; Schaefer K
Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
[No Abstract] [Full Text] [Related]
27. Effect of 1-alpha-hydroxycholecalciferol on magnesium metabolism in chronic renal failure.
Kanis JA; Smith R; Walton RJ; Bartlett M
Br Med J; 1977 Jan; 1(6055):211. PubMed ID: 832080
[No Abstract] [Full Text] [Related]
28. Vitamin D and the syndromes of azotaemic osteodystrophy.
Stanbury SW
Contrib Nephrol; 1978; 13():132-46. PubMed ID: 361340
[TBL] [Abstract][Full Text] [Related]
29. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
Neer RM; Holick MF; DeLuca HF; Potts JT
Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
[TBL] [Abstract][Full Text] [Related]
30. The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.
Peacock M; Davison AM; Walker GS
Adv Exp Med Biol; 1977; 81():559-69. PubMed ID: 899940
[No Abstract] [Full Text] [Related]
31. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure.
Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH
Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943
[No Abstract] [Full Text] [Related]
32. Delayed response to a alpha-hydroxycholecalciferol therapy in a case of hypoparathyroidism during anticonvulsant therapy.
Rubinger D; Korn-Lubetzki I; Feldman S; Popovtzer MM
Isr J Med Sci; 1980 Nov; 16(11):772-4. PubMed ID: 7440128
[TBL] [Abstract][Full Text] [Related]
33. Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3.
Coburn JW; Brickman AS; Hartenbower DL; Norman AW
Adv Exp Med Biol; 1977; 81():549-57. PubMed ID: 899939
[No Abstract] [Full Text] [Related]
34. [Physiologic role, biosynthesis and use of 1,25-dihydroxyvitamin D3 (review)].
Bauman VK
Prikl Biokhim Mikrobiol; 1976; 12(6):805-18. PubMed ID: 799296
[No Abstract] [Full Text] [Related]
35. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
Wong RG; Norman AW; Reddy CR; Coburn JW
J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
[TBL] [Abstract][Full Text] [Related]
36. [Vitamin D physiology and its application to disorders of calcium metabolism].
Favus MJ; Coe FL
Recenti Prog Med; 1981 Feb; 70(2):119-40. PubMed ID: 7027383
[No Abstract] [Full Text] [Related]
37. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
[No Abstract] [Full Text] [Related]
38. The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism.
Breslau NA; McGuire JL; Zerwekh JE; Pak CY
J Clin Endocrinol Metab; 1982 Aug; 55(2):369-73. PubMed ID: 6896338
[TBL] [Abstract][Full Text] [Related]
39. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
[No Abstract] [Full Text] [Related]
40. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease.
Tsuchihashi K; Takizawa H; Torii T; Ikeda R; Nakahara N; Yuda S; Kobayashi N; Nakata T; Ura N; Shimamoto K
Nephron; 2000 Jan; 84(1):13-20. PubMed ID: 10644903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
